Director of Biostatistics

Capricor Therapeutics(28 days ago)

San Diego, CAOnsiteFull TimeDirector$211,181 - $280,265 (estimated)Biostatistics

About this role

The Director of Biostatistics at Capricor Therapeutics leads statistical strategy and execution across clinical development programs for innovative cell and exosome-based therapies. The role oversees internal and outsourced biostatistical activities, ensuring high-quality, compliant analyses that support regulatory submissions and key business objectives. This position represents Biostatistics in regulatory interactions and cross-functional teams while driving innovation in statistical standards and processes. The director operates in a fast-paced environment, managing complex projects that contribute to the advancement of therapies for rare diseases.

View Original Listing

Required Skills

Statistical Strategy
Clinical Trial Design
Data Analysis
Regulatory Submissions
Biostatistics Leadership
Cross Functional Collaboration
Vendor Management
Regulatory Interaction
Protocol Development
Statistical Analysis Plans

+10 more

Qualifications

Master's Degree in Statistics
Master's Degree in Biostatistics
Master's Degree in Related Field
PhD in Statistics
PhD in Biostatistics
PhD in Related Field

About Capricor Therapeutics

capricor.com

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a San Diego–based biotechnology company developing cell- and exosome-based therapeutics for muscular and other select diseases. Its lead candidate, deramiocel (CAP‑1002), is an allogeneic cell therapy currently in Phase 3 clinical development for Duchenne muscular dystrophy. Capricor is also advancing exosome technology as a next‑generation platform, engineering exosomes to deliver nucleic acids and proteins to treat or prevent a variety of diseases. The company focuses on translating these platforms into novel therapeutic and preventive products.